热门资讯> 正文
Oramed Pharmaceuticals authorizes share buyback program
2024-06-26 21:15
- Oramed Pharmaceuticals (NASDAQ:ORMP) said its board has authorized a common stock repurchase plan for the buy-back of up to $20M in maximum value of its common stock.
- Press Release
More on Oramed Pharmaceuticals
- Seeking Alpha’s Quant Rating on Oramed Pharmaceuticals
- Historical earnings data for Oramed Pharmaceuticals
- Financial information for Oramed Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
